Pulsatile Insulin Secretion: Detection, Regulation, and Role in Diabetes

  1. Niels Pørksen1,
  2. Malene Hollingdal1,
  3. Claus Juhl1,
  4. Peter Butler2,
  5. Johannes D. Veldhuis3 and
  6. Ole Schmitz1
  1. 1Department of Endocrinology and Metabolism M, Aarhus University Hospital, Aarhus, Denmark
  2. 2Department of Endocrinology and Diabetes, University of Southern California, Los Angeles, California
  3. 3Department of Medicine and NSF Center for Biological Timing, Charlottesville, Virginia

    Abstract

    Insulin concentrations oscillate at a periodicity of 5–15 min per oscillation. These oscillations are due to coordinate insulin secretory bursts, from millions of islets. The generation of common secretory bursts requires strong within-islet and within-pancreas coordination to synchronize the secretory activity from the β-cell population. The overall contribution of this pulsatile mechanism dominates and accounts for the majority of insulin release. This review discusses the methods involved in the detection and quantification of periodicities and individual secretory bursts. The mechanism by which overall insulin secretion is regulated through changes in the pulsatile component is discussed for nerves, metabolites, hormones, and drugs. The impaired pulsatile secretion of insulin in type 2 diabetes has resulted in much focus on the impact of the insulin delivery pattern on insulin action, and improved action from oscillatory insulin exposure is demonstrated on liver, muscle, and adipose tissues. Therefore, not only is the dominant regulation of insulin through changes in secretory burst mass and amplitude, but the changes may affect insulin action. Finally, the role of impaired pulsatile release in early type 2 diabetes suggests a predictive value of studies on insulin pulsatility in the development of this disease.

    Footnotes

    • Address correspondence and reprint requests to porksen{at}dadlnet.dk.

      Accepted for publication 21 June 2001.

      GLP-1, glucagon-like peptide-1; IGF-1, insulin-like growth factor-1; LH, leutinizing hormone.

      The symposium and the publication of this article have been made possible by an unrestricted educational grant from Servier, Paris.

    « Previous | Next Article »Table of Contents